Patients were instructed to record their food intake and physical activity daily (via paper diary, digital app or similar tool) to assist and evaluate their lifestyle intervention
138(Pt 1):53-68
#AntibodyDrugDiscovery #GPCR #BiopharmaInnovation #AIDrugDiscovery #LifeScienceInvestment To view or add a comment, sign in #AlzheimersDisease has traditionally been associated with amyloid- plaques, but growing evidence underscores the role of neuroinflammation in disease progression
Published human clinical trial data is limited
semaglutide, tirzepatide, and the dual GLP-1/GCGR agonists (survodutide, mazdutide, cotadutide) have not reported a comparable signal at their respective top doses
Based on clinical trial data of the SCALE (Satiety and Clinical AdiposityLiraglutide Evidence) programme, patients are able to lose an average of 8% of their body weight